BridgeDPI: a novel Graph Neural Network for predicting drug–protein interactions

Author:

Wu Yifan12,Gao Min1,Zeng Min2,Zhang Jie134ORCID,Li Min2ORCID

Affiliation:

1. SenseTime Research , Shanghai 200233, China

2. School of Computer Science and Engineering, Central South University , Changsha 410083, China

3. Qing Yuan Research Institute, Shanghai Jiao Tong University , Shanghai 200240, China

4. Merck Advisory Committee for AI-enabled Health Solution , Shanghai 200126, China

Abstract

Abstract Motivation Exploring drug–protein interactions (DPIs) provides a rapid and precise approach to assist in laboratory experiments for discovering new drugs. Network-based methods usually utilize a drug–protein association network and predict DPIs by the information of its associated proteins or drugs, called ‘guilt-by-association’ principle. However, the ‘guilt-by-association’ principle is not always true because sometimes similar proteins cannot interact with similar drugs. Recently, learning-based methods learn molecule properties underlying DPIs by utilizing existing databases of characterized interactions but neglect the network-level information. Results We propose a novel method, namely BridgeDPI. We devise a class of virtual nodes to bridge the gap between drugs and proteins and construct a learnable drug–protein association network. The network is optimized based on the supervised signals from the downstream task—the DPI prediction. Through information passing on this drug–protein association network, a Graph Neural Network can capture the network-level information among diverse drugs and proteins. By combining the network-level information and the learning-based method, BridgeDPI achieves significant improvement in three real-world DPI datasets. Moreover, the case study further verifies the effectiveness and reliability of BridgeDPI. Availability and implementation The source code of BridgeDPI can be accessed at https://github.com/SenseTime-Knowledge-Mining/BridgeDPI. The source data used in this study is available on the https://github.com/IBM/InterpretableDTIP (for the BindingDB dataset), https://github.com/masashitsubaki/CPI_prediction (for the C.ELEGANS and HUMAN) datasets, http://dude.docking.org/ (for the DUD-E dataset), repectively.

Funder

National Natural Science Foundation of China

Human Provincial Science and Technology Program

Publisher

Oxford University Press (OUP)

Subject

Computational Mathematics,Computational Theory and Mathematics,Computer Science Applications,Molecular Biology,Biochemistry,Statistics and Probability

Reference50 articles.

1. The $2.6 billion pill–methodologic and policy considerations;Avorn;N. Engl. J. Med,2015

2. A machine learning approach to predicting protein–ligand binding affinity with applications to molecular docking;Ballester;Bioinformatics,2010

3. Supervised prediction of drug–target interactions using bipartite local models;Bleakley;Bioinformatics,2009

4. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro;Caly;Antiviral Res,2020

5. Hidden bias in the dud-e dataset leads to misleading performance of deep learning in structure-based virtual screening;Chen;PLoS One,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3